文摘
Objectives To compare the potential of T1 mapping on gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) for assessing liver function in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Methods One hundred consecutive patients with known HBV-related HCCs were included. T1 relaxation time and apparent diffusion coefficient (ADC) of the liver were measured, and the reduction rate of T1 relaxation time (?) was calculated. T1 relaxation time measurements were compared with ADC values according to the Model for End-Stage Liver Disease (MELD) score. Results Hepatobiliary phase (HBP) and ? of T1 relaxation time measurements showed significant correlations with MELD score (rho--.571, p--.0001; rho-??0.573, p--.0001, respectively). HBP and ? of T1 relaxation time were significantly different between good (MELD ?) and poor liver function (MELD ?) (p--.0001 for both). Areas under the receiver operating characteristic curves (AUCs) of T1 relaxation time for HBP (AUC 0.84) and ? (AUC 0.82) were significantly better than for ADC (AUC 0.53; p--.0001). Conclusions T1 mapping on Gd-EOB-DTPA-enhanced MRI showed promise for evaluating liver function in patients with HBV-related HCC, while DWI was not reliable. HBP T1 relaxation time measurement was equally accurate as ? measurement. Key Points -T 1 mapping on Gd-EOB-DTPA MRI was accurate for assessing liver function. -HBP T 1 relaxation time measurement was as accurate as ??T 1 -T 1 mapping on Gd-EOB-DTPA MRI was more accurate than DWI-ADC measurement.